<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="105746">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01720862</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00051683</org_study_id>
    <nct_id>NCT01720862</nct_id>
  </id_info>
  <brief_title>Migraine and Body Composition</brief_title>
  <official_title>Migraine and Body Composition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research is being done to look at the association between migraine and obesity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Research into the role of inflammatory markers and other obesity related proteins and
      chemicals may  help us understand migraine and lead to new treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2012</start_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>association between migraine and obesity - evaluate serum adipokine levels</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>The first aim of the proposed research is to evaluate serum adipokine levels in a clinical cohort of obese and non-obese episodic and chronic migraineurs and examine their utility as markers of the presence or absence of migraine and their relationship to headache frequency.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>association between migraine and obesity -evaluate subcutaneous adipose tissue (SAT) and its ratio to visceral adipose tissue (VAT)</measure>
    <time_frame>five years</time_frame>
    <safety_issue>No</safety_issue>
    <description>The second aim of the proposed research is to evaluate subcutaneous adipose tissue (SAT) and its ratio to visceral adipose tissue (VAT),in the same clinical cohort of migraineurs to determine if regional adipose tissue differences exist between: (1) episodic migraineurs, (2) chronic migraineurs and (3) controls, thus contributing to the migraine-obesity relationship.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Migraine With and Without Aura</condition>
  <condition>Chronic Migraine</condition>
  <condition>Healthy Controls</condition>
  <arm_group>
    <arm_group_label>Episodic migraineurs</arm_group_label>
    <description>Those with migraines &gt;2 and &lt; 12 times per month.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chronic migraineurs</arm_group_label>
    <description>Those with migraines greater than 14 days per month.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Those without headaches other than occasional hangover, cold, flu headaches.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Premenopausal Caucasian women ages 18-55 years with or without migraine.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Premenopausal women (18-55 years)

          -  Normal weight (BMI = 18.5 - 24.9) or obese (BMI â‰¥ 30)

          -  Diagnosis of episodic or chronic migraine or pain free control

        Exclusion Criteria:

          -  Evidence of pain disorder other than migraine (e.g. irritable bowel    syndrome)

          -  Chronic conditions known to alter risk or pattern of migraine (e.g. hypothyroidism)

          -  Illnesses that may affect adipokine levels (e.g. diabetes)

          -  Clinically relevant abnormal glucose/cholesterol levels

          -  Pregnant women

          -  Potential participants who are unable to undergo MRI based on standard screening
             questionnaire (those with brain aneurysm or surgical clips, certain types of
             artificial heart valves, heart defibrillator or pacemaker, cochlear implants, eye
             implants, blood vessel coil,  recently placed artificial joints, certain types of
             vascular stents, history of bullets, pellets, BBs, history of any implanted metal or
             device or who have worked with sheet metal in the past)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barbara L Peterlin, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Barbara L Peterlin, D.O.</last_name>
    <phone>410-550-9550</phone>
    <email>lpeterlin@jhmi.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Linda W White, CRNP</last_name>
    <phone>410-550-4418</phone>
    <email>lwhite@jhmi.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Johns Hopkins Bayview Headache Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara L Peterlin, D.O.</last_name>
      <phone>410-550-9550</phone>
      <email>lpeterlin@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>Linda W White, CRNP</last_name>
      <phone>410-550-4418</phone>
      <email>lwhite@jhmi.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Barbara L Peterlin, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <lastchanged_date>November 1, 2012</lastchanged_date>
  <firstreceived_date>October 31, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins University</investigator_affiliation>
    <investigator_full_name>Drs Barbara Peterlin</investigator_full_name>
    <investigator_title>Director of Headache Research, Johns Hopkins Bayview</investigator_title>
  </responsible_party>
  <keyword>migraine</keyword>
  <keyword>episodic migraine</keyword>
  <keyword>chronic migraine</keyword>
  <keyword>obesity</keyword>
  <keyword>non-obese</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
